About thecannabispages

This author has not yet filled in any details.
So far thecannabispages has created 1463 blog entries.

Long-term cannabis use not linked to cognitive decline — study

By |2024-11-20T03:12:41+00:0020 November 2024|

New research has found no association between long-term cannabis use and cognitive decline in later life.  Longitudinal data published in the journal Brain and Behavior, found no significant harmful effects of cannabis use on age-related cognitive decline.  Researchers in Denmark examined the relationship between lifetime cannabis [...]

NHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access

By |2024-11-07T03:04:10+00:007 November 2024|

Six years on from the legalisation of medical cannabis in the UK, families have made a fresh call for NHS access, as new figures reveal lack of prescribing. Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, [...]

Comments Off on NHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access

Oireachtas Committee Pushes Decriminalisation of Cannabis in Ireland

By |2024-11-06T03:21:46+00:006 November 2024|

The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of Ireland’s landmark Citizens’ Assembly on Drugs Use, coming out strongly in favour of decriminalisation. Established earlier this year to further scrutinise the recommendations of the Citizens Assembly, the specialist committee was given until [...]

Comments Off on Oireachtas Committee Pushes Decriminalisation of Cannabis in Ireland

UK Medical Cannabis: Marking Six Years of Access & Looking Ahead

By |2024-11-02T03:12:14+00:002 November 2024|

Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients [...]

Comments Off on UK Medical Cannabis: Marking Six Years of Access & Looking Ahead

Dramatic drop in cannabis use among US teens, finds study

By |2024-11-01T03:00:21+00:001 November 2024|

New findings have identified a significant decline in the percentage of US adolescents reporting current cannabis use over the last decade.  The study, published in the journal Pediatric Reports, reveals that in 2011, 23.1% of adolescents indicated they were current users, but by 2021, this figure [...]

Comments Off on Dramatic drop in cannabis use among US teens, finds study

Nationwide awareness drive to mark six years of medical cannabis in the UK

By |2024-10-31T03:03:52+00:0031 October 2024|

Events will take place at several major cities around the UK to raise awareness and bring medical cannabis education directly to the public.  Patient advocates will visit Belfast, Birmingham, Glasgow, Cardiff and London throughout Medical Cannabis Awareness Week (1-7 November), to share their personal experiences and [...]

Comments Off on Nationwide awareness drive to mark six years of medical cannabis in the UK

The Hidden Dangers of Illicit Cannabis

By |2024-10-25T03:05:52+01:0025 October 2024|

A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re committed to providing the highest standard of medical cannabis care, guided by science. As such, we are concerned about the growing number of people buying cannabis from illegal sources, including online [...]

Comments Off on The Hidden Dangers of Illicit Cannabis

118% Surge in UK Cannabis Prescriptions Highlights Awareness Challenges

By |2024-10-25T03:05:37+01:0025 October 2024|

Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind. After almost six years of medical cannabis being available on prescription in the UK, the numbers [...]

Comments Off on 118% Surge in UK Cannabis Prescriptions Highlights Awareness Challenges

Economic analysis finds medical cannabis could save NHS £4 billion each year

By |2024-10-24T03:10:05+01:0024 October 2024|

Prescribing medical cannabis for chronic pain could save the NHS almost £4 billion annually, according to new research. The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain, undertaken by York Health-Economics Consortium at the University of York.  Researchers [...]

Comments Off on Economic analysis finds medical cannabis could save NHS £4 billion each year

Germany Green-Lights Changes to Medical Cannabis Prescription Process

By |2024-10-23T03:07:12+01:0023 October 2024|

The majority of doctors in Germany can now prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies. It comes amid reports suggesting the German pharmacies are now key beneficiaries of the medical cannabis market, bringing in tens of thousands of euros [...]

Comments Off on Germany Green-Lights Changes to Medical Cannabis Prescription Process

New publication evidences role of medical cannabis in epilepsy

By |2024-10-18T03:11:09+01:0018 October 2024|

UK medical cannabis experts have published a comprehensive review of evidence for the prescription of cannabis-based medicines in epilepsy. With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy, published by Maple Tree Consultants, provides the first review of nearly 100 clinical trials, real-world studies, and [...]

Comments Off on New publication evidences role of medical cannabis in epilepsy

Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024

By |2024-10-18T03:11:00+01:0018 October 2024|

Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. [...]

Comments Off on Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024

UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For

By |2024-10-18T03:10:46+01:0018 October 2024|

By Sarah Sinclair with additional reporting from Ben Stevens (Business of Cannabis) Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy. The first significant update on the trials—first promised in [...]

Comments Off on UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For

UK Private Medical Cannabis Market Sees Exponential Growth, Doubling Yearly Since 2021

By |2024-10-18T03:10:30+01:0018 October 2024|

The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion. According to the latest figures from the NHS Business Services Authority (NHSBSA), published in response to an FOI request, the number of [...]

Comments Off on UK Private Medical Cannabis Market Sees Exponential Growth, Doubling Yearly Since 2021

Ukraine excludes PTSD from list of approved conditions for medical cannabis

By |2024-10-10T03:01:52+01:0010 October 2024|

Ukraine’s Ministry of Health has approved the draft list of conditions for which medical cannabis can now be prescribed, excluding PTSD and other mental health disorders until more research is available. The impact of trauma and PTSD following Russia’s invasion of Ukraine played a key role [...]

Comments Off on Ukraine excludes PTSD from list of approved conditions for medical cannabis

Clinical trial shows dronabinol reduces agitation in Alzheimer’s disease

By |2024-10-09T03:16:33+01:009 October 2024|

The THC-based drug dronabinol has been shown to reduce agitation in Alzheimer’s patients without adverse effects. Researchers have shown that a pill form of the drug dronabinol, an FDA-approved synthetic version of THC, reduces agitation in patients with Alzheimer’s by an average of 30%. The researchers [...]

Comments Off on Clinical trial shows dronabinol reduces agitation in Alzheimer’s disease

Spain’s proposed medical cannabis framework too ‘restrictive’, say patients

By |2024-10-03T03:08:22+01:003 October 2024|

Spanish regulators have taken another step towards introducing the country’s long-delayed medical cannabis framework, but patients say the legislation does not go far enough. On Monday 30 September, the Ministry of Health published a draft royal decree for public hearing, setting out the proposed regulations for [...]

Comments Off on Spain’s proposed medical cannabis framework too ‘restrictive’, say patients

National education programs needed to tackle ‘stigma’ and ‘inequality’ facing medical cannabis patients

By |2024-10-02T03:11:59+01:002 October 2024|

Drug policy experts are calling for national education programs to tackle the lack of awareness and ‘stigmatising attitudes’ towards medical cannabis patients. In a new paper, researchers from Liverpool John Moores University, have highlighted how current policies, and a lack of training for professionals, are contributing [...]

Comments Off on National education programs needed to tackle ‘stigma’ and ‘inequality’ facing medical cannabis patients

New poll sheds light on patterns of cannabis use among over 50s

By |2024-09-27T03:10:37+01:0027 September 2024|

A large percentage of people in their 50s and older have consumed at least one form of cannabis in the past year, a new US poll shows. According to new findings from the University of Michigan National Poll on Healthy Aging, 21% of people aged 50 [...]

Comments Off on New poll sheds light on patterns of cannabis use among over 50s

Study finds no link between long-term medical cannabis use and changes in brain function

By |2024-09-26T03:06:11+01:0026 September 2024|

A new study, funded by the US National Institute on Drug Abuse, found no association between long-term medical cannabis use and changes in brain function related to memory, reward or self-control. The study is thought to be among the first to examine long-term brain differences among [...]

Comments Off on Study finds no link between long-term medical cannabis use and changes in brain function

France’s medical cannabis launch likely to be delayed until 2026

By |2024-09-25T03:02:12+01:0025 September 2024|

Via Newsweed While the French National Agency for the Safety of Medicines (ANSM) assured at the beginning of the year that cannabis-based treatments would be available by 2025, it will be difficult to achieve widespread use of medical cannabis in France before 2026. In order to [...]

Comments Off on France’s medical cannabis launch likely to be delayed until 2026

Most Germans are consuming cannabis for health reasons—but many still access it illegally

By |2024-09-24T05:26:37+01:0024 September 2024|

A new survey following the landmark law change in Germany has revealed that the majority of people consuming cannabis are doing so for health issues. Frankfurt- based medical cannabis company Bloomwell GmbH conducted a representative survey exploring the reasons why Germans use cannabis following the change [...]

Comments Off on Most Germans are consuming cannabis for health reasons—but many still access it illegally

Landlords warned cannabis policies could be at risk of breaching the Equality Act

By |2024-09-21T03:09:04+01:0021 September 2024|

UK landlords, property managers, and housing associations are currently at risk of breaching the Equality Act over their approach to prescription cannabis, according to a new report. The new report by the Cannabis Industry Council (CIC) urges housing providers to support tenants who may be prescribed [...]

Comments Off on Landlords warned cannabis policies could be at risk of breaching the Equality Act

UK cannabis clinics Leva and Zerenia merge to expand patient care

By |2024-09-21T03:08:56+01:0021 September 2024|

UK medical cannabis providers, Leva Clinic and Zerenia Clinic, have announced a new merger to improve treatment options available to patients with chronic pain. The partnership combines Leva Clinic’s expertise in pain management with Zerenia’s holistic healthcare approach, offering patients across the UK greater access to [...]

Comments Off on UK cannabis clinics Leva and Zerenia merge to expand patient care

New review sheds light on risks of cannabis use in pregnancy

By |2024-09-21T03:08:49+01:0021 September 2024|

A new study offers more insights into the complex relationship between prenatal cannabis exposure and neuropsychiatric outcomes in children.  As the global trend toward cannabis legalisation continues, the prevalence of cannabis use among pregnant women is on the rise, raising concerns about its impact on foetal [...]

Comments Off on New review sheds light on risks of cannabis use in pregnancy

CBD found to improve symptoms and extend lifespan in Leigh syndrome

By |2024-09-19T03:03:25+01:0019 September 2024|

A new study has demonstrated how daily administration of cannabidiol (CBD), can extend lifespan and improve symptoms associated with Leigh syndrome.  Leigh syndrome is a rare and severe mitochondrial disease affecting around one in 40,000 children and young people. There are currently no approved treatments for the [...]

Comments Off on CBD found to improve symptoms and extend lifespan in Leigh syndrome

CBD suppositories reduce severity and frequency of period pain – study

By |2024-09-18T03:13:32+01:0018 September 2024|

CBD suppositories have been found to significantly reduce the frequency and severity of menstrual pain compared to traditional painkillers. A new study published in Nature Partner Journal: Women’s Health is the first to examine the impact of a ‘real-world’ commercially-available, high-CBD suppository on menstrual-related pain and [...]

Comments Off on CBD suppositories reduce severity and frequency of period pain – study

Exposures to Delta-8 THC lower in US states where cannabis is legal – study

By |2024-09-05T03:10:57+01:005 September 2024|

The number of exposures to Delta 8-THC increased by 79% from 2021 to 2022, with reports ‘significantly lower’ in states with access to legal cannabis.  Recent years have seen a rapid increase in the availability of synthetic cannabinoids with similar effects to the naturally-occurring Delta-9 THC.  [...]

Comments Off on Exposures to Delta-8 THC lower in US states where cannabis is legal – study

Anxiety and PTSD most common reasons for medical cannabis use among under 21s, reveals US study

By |2024-09-03T03:04:24+01:003 September 2024|

A new peer-reviewed study is one of the first to examine medical cannabis use among those under the age of 21 in the United States.  The findings show that under-21 patients are accessing medicinal cannabis for most of the same reasons as adults – with almost [...]

Comments Off on Anxiety and PTSD most common reasons for medical cannabis use among under 21s, reveals US study

Cannabis linked to ‘substantial improvements’ in endometriosis symptoms

By |2024-08-30T03:11:51+01:0030 August 2024|

A new study, based on the experiences of endometriosis patients in Europe, has found cannabis to have a significant impact on wellbeing and quality of life, leading to ‘substantial improvements’ in symptoms. Researchers surveyed over 900 patients based in Germany, Switzerland and Austria about their use [...]

Comments Off on Cannabis linked to ‘substantial improvements’ in endometriosis symptoms

THC has anti-ageing and cognition enhancing effects, finds study

By |2024-08-29T03:05:49+01:0029 August 2024|

Long-term treatment with THC has been found to have cognition enhancing and anti-ageing effects, according to new research.  Researchers from the University Hospital Bonn (UKB) and the University of Bonn together with a team from Hebrew University (Israel) have demonstrated in animal studies that a low-dose, [...]

Comments Off on THC has anti-ageing and cognition enhancing effects, finds study

Ukraine legalises medical cannabis, but are PTSD patients being left behind?

By |2024-08-28T03:12:00+01:0028 August 2024|

Last week, Ukraine’s law officially legalising medical cannabis came into effect, eight months after initially being passed. Despite the positive progress, the list of diseases for which it will be prescribed, currently being decided upon by the Ministry of Health, does not yet include Post-Traumatic Stress [...]

Comments Off on Ukraine legalises medical cannabis, but are PTSD patients being left behind?

Grounding of British Airways flight sparks calls for more medical cannabis education

By |2024-08-23T03:01:32+01:0023 August 2024|

An incident on board a British Airways flight has sparked further calls for police and other organisations to be better informed of medical cannabis laws. The British Airways flight travelling from London City Airport to Amsterdam on 28 June, was grounded for hours by armed police [...]

Comments Off on Grounding of British Airways flight sparks calls for more medical cannabis education

Over 30% of Parkinson’s patients use natural health products, finds survey

By |2024-08-22T03:06:22+01:0022 August 2024|

A recent survey has found that over a third of patients with Parkinson’s disease are turning to natural remedies, including cannabis, coffee and turmeric, to help manage their symptoms.  The study, published in the Journal of Parkinson’s, also revealed that a large number of these patients [...]

Comments Off on Over 30% of Parkinson’s patients use natural health products, finds survey

Landmark Philippine medical cannabis legalisation bill could position country as frontrunner in the region

By |2024-08-21T03:16:02+01:0021 August 2024|

Earlier this month, the Philippine House of Representatives voted overwhelmingly in favour of a bill that would legalise medical cannabis, marking a significant step forward for cannabis liberalisation in Southeast Asia. House Bill 10439, which was initially submitted in May, 2024, received its third and final [...]

Comments Off on Landmark Philippine medical cannabis legalisation bill could position country as frontrunner in the region

Study points to benefits of cannabis for reducing opioid use and symptoms of withdrawal

By |2024-08-17T03:02:52+01:0017 August 2024|

A new study highlights how cannabis can be a helpful tool for reducing opioid use and providing ‘rapid relief’ from symptoms of withdrawal. The study, which received funding from the National Institute of Drug Abuse (NIDA), comes following a surge in overdose mortality rates over the [...]

Comments Off on Study points to benefits of cannabis for reducing opioid use and symptoms of withdrawal

How much does medical cannabis cost in the UK? Releaf’s price plans explained

By |2024-08-16T03:10:18+01:0016 August 2024|

Written by Releaf To establish whether medical cannabis is the right option for you, you need to know whether it’s within your budget. Here, Releaf breaks down how much it all costs and the different plans available. Market research has shown that one of the most [...]

Comments Off on How much does medical cannabis cost in the UK? Releaf’s price plans explained

Blue Light Card holders to benefit from more affordable medical cannabis

By |2024-08-16T03:10:11+01:0016 August 2024|

Blue Light Card holders, including emergency service workers and health and social care staff can now access medical cannabis at a reduced cost, following the expansion of a UK initiative. Medical cannabis distributor, Grow Pharma, has announced the expansion of its access scheme, the Grow Access [...]

Comments Off on Blue Light Card holders to benefit from more affordable medical cannabis

The tipping point? UK cannabis clinics urged to clean up ‘concerning’ prescribing practices

By |2024-08-14T03:09:14+01:0014 August 2024|

As the UK medical cannabis industry reaches a ‘tipping point’, experts are urging clinics to follow best practice guidelines, as regulators look to crackdown on what has been described as a ‘pseudo-recreational market’.  Health and social care watchdog, the Care Quality Commission (CQC) recently reported a [...]

Comments Off on The tipping point? UK cannabis clinics urged to clean up ‘concerning’ prescribing practices

UK medical cannabis cards – what you need to know

By |2024-08-09T03:10:33+01:009 August 2024|

Written by Releaf Releaf offers every patient at the clinic a medical cannabis card to help ensure ease and peace of mind when going about daily life with your prescription. In this article, we explain all you need to know about how it works. Despite medical [...]

Comments Off on UK medical cannabis cards – what you need to know

Transform prepares to launch UK cannabis legalisation campaign

By |2024-08-08T03:04:38+01:008 August 2024|

The independent drug policy foundation, Transform, is fundraising to launch a national campaign to accelerate cannabis reform in the UK. The charity is hoping to raise £50,000 to support its work in bringing “responsible cannabis regulation” to the UK. Polls show that more than half of [...]

Comments Off on Transform prepares to launch UK cannabis legalisation campaign

Don’t Reinvent The Wheel: A Tour of ASTM Standards for Cannabis and Hemp – Part 2

By |2024-08-07T03:04:20+01:007 August 2024|

In our previous article, we delved into the foundational ASTM International standards that are shaping the cannabis and hemp industries. We explored the first true universal symbol for cannabis, water activity controls, and Hazard Analysis and Critical Control Points (HACCP) standards. As we continue this journey, [...]

Comments Off on Don’t Reinvent The Wheel: A Tour of ASTM Standards for Cannabis and Hemp – Part 2

S3 Collective and MCSA File Public Comment Response to Proposed Cannabis Rescheduling

By |2024-08-07T03:04:16+01:007 August 2024|

S3 Collective and the Medical Cannabis Student Association (MCSA) have submitted a comprehensive public comment to the Department of Justice (DOJ) and Drug Enforcement Administration (DEA) supporting the reclassification of cannabis to Schedule III under the Controlled Substances Act. This official response to Docket No. 2024-11137 [...]

Comments Off on S3 Collective and MCSA File Public Comment Response to Proposed Cannabis Rescheduling

Medical cannabis for elderly patients: everything you need to know

By |2024-07-31T03:02:02+01:0031 July 2024|

Written by Releaf With medical cannabis showing promise among elderly patients, UK cannabis clinic, Releaf, examines its efficacy, safety profile, and other things to consider when exploring this treatment option for yourself or a loved one. Since medical cannabis was legalised in the UK almost six [...]

Comments Off on Medical cannabis for elderly patients: everything you need to know

Germany proposes major overhaul in medical cannabis prescription process

By |2024-07-31T03:01:53+01:0031 July 2024|

Germany’s Federal Joint Committee (G-BA) has proposed significant changes to the medical cannabis prescription process, set to have a major impact on the country’s already booming market. Germany’s private or ‘self funded’ medical cannabis market has exploded since the introduction of CanG on April 01, which [...]

Comments Off on Germany proposes major overhaul in medical cannabis prescription process

Minor cannabinoids show ‘promising anti-cancer’ effects, finds study

By |2024-07-25T03:03:25+01:0025 July 2024|

Minor cannabinoids CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer. Cannabinoids are now widely prescribed to palliative cancer patients to help manage symptoms, as well as the side-effects of conventional treatments such as chemotherapy.  They have also [...]

Comments Off on Minor cannabinoids show ‘promising anti-cancer’ effects, finds study